Leadless Pacemaker Systems Market Size, Share, Growth, Forecast 2030

The global Leadless Pacemaker Systems Market accrued earnings worth approximately 55 (USD Million) in 2021 and is predicted to gain revenue of about 98 (USD Million) by 2028, is set to record a CAGR of nearly 10.1% over the period from 2022 to 2028.

Request Free Sample

The study provides assessment and analysis of the Leadless Pacemaker Systems Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Million).

Leadless Pacemaker Systems Market: Overview

Leadless pacemaker systems are self-contained generators & electrode systems implanted directly into right ventricle of human body. The device is inserted through femoral vein transcatheter approach and needs no chest incision and sub-cutaneous generator pocket. Key benefit of leadless pacemaker system is eliminating large number of complications related to transvenous pacemakers & leads, hematoma, lead fracture, pocket infections, and lead dislodgement. Leadless pacemakers can be suited to patients having permanent atrial fibrillation due to bradycardia or those that need pacing regularly. However, leadless pacemaker systems are not appropriate for subjects requiring dual-chamber pacing. For instance, patients having particular kinds of heart block as well as sinus node dysfunction.

Request Free Sample

Leadless Pacemaker Systems Market: Growth Drivers

Surge in cardiovascular diseases and increase in geriatric population prone to heart ailments will create huge scope of growth for leadless pacemaker systems industry. Favorable reimbursement policies and elongated battery life has made use of leadless pacemaker systems popular in healthcare sector. Breakthroughs in pacemaker technology and growing tilt towards minimally invasive surgeries & treatment will pave a way for massive growth of leadless pacemaker systems industry in ensuing years. Supportive government laws promoting healthcare activities along with surge in allocation of funds for healthcare industry will drive expansion of leadless pacemaker systems market. Nonetheless, high implantation costs and lack of trained personnel for performing leadless pacemaker implants can pose a threat to expansion of leadless pacemaker systems industry.

Leadless Pacemaker Systems Market: Report Scope

Furthermore, no threat of scars & infections and MRI compatibility will translate into huge growth of leadless pacemaker systems industry. No requirement of post-operative mobility restriction will further steer growth of leadless pacemaker systems market. Product innovations and launching of new technologies in healthcare sector will create lucrative opportunities for leadless pacemaker systems industry.

Leadless Pacemaker Systems Market: Competitive Landscape

Key players establishing a deeper impact on leadless pacemaker systems market growth and included in report are Abbott Laboratories, Biotronik, Medtronic PLC, EBR Systems, Inc., and Boston Scientific Corporation.

Leadless Pacemaker Systems Market: Regional Landscape

North America Contributed Immensely Towards Regional Market Share By 2028

Expansion of leadless pacemaker systems industry in North America over forecasting timeline is subject to rise in occurrence of heart ailments along with swift acceptance of leadless cardiac pacemakers. Additionally, favorable compensation policies and surge in number of patients suffering from atrial fibrillation will translate into humungous growth of regional market.

Request Free Sample

Apart from this, large-scale presence of giant medical device manufacturing firms in sub-continent has contributed majorly towards leadless pacemaker systems market rewards in North America.

Leadless Pacemaker Systems Market: Competitive Space

The global Leadless Pacemaker Systems market profiles key players such as:

• Abbott Laboratories
• Biotronik
• Medtronic PLC
• EBR Systems Inc
• Boston Scientific Corporation

The global Leadless Pacemaker Systems Market is segmented as follows:

By Product

• Micra Transcatheter Pacing System
• Nanostim Leadless Pacemaker
• Others

 By End-User

• Hospitals
• Ambulatory Surgical Units

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa